Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Perceptions of barriers and facilitators to opioid reduction after total joint arthroplasty among orthopedic surgeons practicing in Canada, Japan, and the Netherlands: A qualitative description study

  • Mansi Patel,

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing

    Affiliation Division of Orthopaedics, Department of Surgery, McMaster University, Hamilton, ON, Canada

  • Parsia Parnian,

    Roles Data curation, Formal analysis, Investigation, Software, Writing – original draft, Writing – review & editing

    Affiliation Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada

  • Kim Madden,

    Roles Conceptualization, Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliations Division of Orthopaedics, Department of Surgery, McMaster University, Hamilton, ON, Canada, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

  • Sheila Sprague,

    Roles Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliations Division of Orthopaedics, Department of Surgery, McMaster University, Hamilton, ON, Canada, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

  • Anita Acai,

    Roles Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliations Department of Psychiatry & Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada, McMaster Education Research, Innovation and Theory (MERIT) Program, McMaster University, Hamilton, ON, Canada, St. Joseph’s Education Research Centre (SERC), St. Joseph’s Healthcare Hamilton, Hamilton, ON, Canada

  • Ydo Kleinlugtenbelt,

    Roles Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, Netherlands

  • Natsumi Saka,

    Roles Data curation, Investigation, Resources, Writing – review & editing

    Affiliation Department of Orthopedic Surgery, Teikyo University School of Medicine, Tokyo, Japan

  • Ellie Landman,

    Roles Investigation, Methodology, Project administration, Resources, Supervision, Writing – review & editing

    Affiliation Department of Orthopedic and Trauma Surgery, Deventer Ziekenhuis, Deventer, Netherlands

  • Harsha Shanthanna,

    Roles Methodology, Resources, Writing – review & editing

    Affiliation Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

  • Vickas Khanna,

    Roles Investigation, Methodology, Resources, Writing – review & editing

    Affiliation Division of Orthopaedics, Department of Surgery, McMaster University, Hamilton, ON, Canada

  • Jason W. Busse

    Roles Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing

    bussejw@mcmaster.ca

    Affiliations Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada, Department of Anesthesia, McMaster University, Hamilton, ON, Canada

Abstract

Opioid analgesics are commonly prescribed after total knee and hip arthroplasty to manage pain. Rates of opioid prescribing after arthroplasty differ by country, suggesting differences in policies or surgeons’ practices. We adopted a qualitative description design to explore and compare Canadian, Dutch, and Japanese orthopaedic surgeons’ perceptions of facilitators and barriers to opioid reduction after total joint arthroplasty. We used a combination of convenience and purposive sampling, and snowball recruitment to facilitate 27 semi-structured interviews online or via a phone call. We concurrently collected and analyzed data using conventional (inductive) content analysis. In our sample, all Canadian surgeons and almost all Dutch surgeons prescribed opioids to all arthroplasty patients post-discharge. Surgeons in Japan showed much greater variability, with half of those interviewed prescribing opioids to only a minority or no patients post-discharge. Japanese surgeons indicated that a 10–30-day hospital stay was typical after surgery and believed that opioids were often unnecessary for managing postoperative pain. Dutch surgeons described using an institutional standard pain management protocol, while Canadian and Japanese surgeons noted high variability in the type and dose of opioids prescribed, even within the same institution. Orthopaedic surgeons in each country identified challenges and facilitators to reduced postoperative opioid use in six key areas: (1) opioid prescribing practices, (2) patient factors, (3) collaborative care, (4) opioid prescribing policies/guidelines, (5) surgeon education, and (6) personal perceptions/beliefs. Canadian, Dutch, and Japanese orthopedic surgeons in our study described a range of individual, patient, and system level contributors to variability in opioid prescribing after joint replacement surgery. These findings suggest that multifactorial and context-specific approaches may be required to address barriers and optimize postoperative use of opioids.

Introduction

The prevalence of osteoarthritis (OA) is increasing, and total joint arthroplasty (TJA) is a commonly used procedure to address advanced stages of the disease. However, approximately 29% of patients report experiencing moderate to severe acute pain after total hip arthroplasty (THA) and 51% after total knee arthroplasty (TKA) [1]. Consequently, opioids are often prescribed in the acute postoperative period after joint replacement surgery in many countries [2]. However, the increase in opioid prescribing has contributed to the current opioid crisis, referring to the increase in the incidence of deaths and hospitalizations resulting from the rising use of prescription and non-prescription opioids [3]. Variations in opioid prescribing and consumption across countries suggest disparities in healthcare systems, policies, and surgeon perspectives [46].

Canada

North America is at the heart of the opioid crisis, with Canada and the USA leading in the per-person consumption of prescription opioids globally [7]. The opioid crisis primarily emerged due to the insufficient regulation and profit-driven motives of the pharmaceutical and healthcare industries, which nearly quadrupled opioid prescribing [7]. There were 22,828 deaths from opioid toxicity between 2016 and 2021 in Canada, with 6,946 deaths occurring during the COVID-19 pandemic between April 2020 to March 2021 [8].

The Netherlands

In the Netherlands, between 2008 and 2017, the cumulative number of opioid prescriptions nearly doubled, with a concordant increase in misuse [9]. Between 2007 and 2016, deaths caused by opioid overdose in Europe were 1.2 deaths per 100000 per year, compared to 15 deaths per 100000 in the USA [10]. Opioid misuse in the Netherlands is substantially lower than in North America, including opioid-related mortality, though it is much greater than in Japan [9,11]. Concerns about opioid use in the Netherlands are predominantly due to marketing by pharmaceutical companies directed to the surgeon, and surgeon preferences [9].

Japan

The per capita use of six potent opioids is 26 times higher in the USA than in Japan despite a similar prevalence of chronic pain. Orthopaedic surgeons in Japan prescribe significantly fewer postoperative opioids compared to North America [4]. Japan was the first Asian country to enact modern legislation in the 19th century to regulate opioid consumption strictly [4,12]. Therefore, in the last couple of decades, Japan has not experienced substantial issues with opioid addiction and related consequences [4].

Rationale

Comparing and understanding perceptions of facilitators and barriers to reducing the use of opioids in distinct jurisdictions may inform the willingness of surgeons to revisit their prescribing practices. It may also aid in identifying potential best practices that can be shared among countries to enhance patient outcomes and promote safer pain management practices. We therefore conducted a qualitative study to explore: (1) perceptions of opioid prescribing after joint replacement, and (2) facilitators and barriers to opioid reduction after TKA or THA in three jurisdictions that represent high (Canada), moderate (The Netherlands), and low (Japan) opioid prescribing practices.

Methods

Research design

We used a qualitative description design, commonly employed to provide descriptive accounts of health care phenomena. Qualitative description methodology emphasizes an analytical and data-driven perspective to prioritize the practical implications of findings for healthcare providers, educators, and policymakers [1316].

Sampling and recruitment

Surgeons from Canada, the Netherlands, and Japan were sampled. We recruited surgeons who understood and spoke English and routinely performed hip or knee arthroplasty via convenience sampling. This entailed contacting surgeons within our personal and professional networks who we knew either prescribed or did not prescribe opioids. We used non-probability, purposive sampling to intentionally “select” participants who could provide a rich account of the phenomena of interest [16,17]. We also used snowball recruitment, where initial participants recommended additional contacts in the same country who fit the research criteria and were willing to partake in the study. We sought maximum variation in academic versus community practice locations, gender, and years of practice. We also recruited participants via our professional social media accounts (i.e., Instagram and Twitter) and email.

Interview guide

We used a semi-structured interview guide, which consisted of a series of open-ended questions to capture the perceptions of surgeons on barriers and facilitators to reduced opioid prescribing after discharge following TKA or THA (S1 File). The research objectives, the team members’ clinical experiences and perceptions of important topics, and past literature concomitantly informed the development of this interview guide [18,19].

Data collection

Trained research assistants conducted semi-structured interviews via Zoom or phone with 11 Canadian, 9 Dutch, and 7 Japanese orthopaedic surgeons. One interview with a Dutch surgeon included an anesthesiologist as well. We provided Japanese surgeons with an option to access a translator if needed. Data saturation was reached after no new themes were developed from data analysis, and we completed two subsequent interviews in each country to verify [16]. Interviews were completed between November 2022 and February 2023, lasting between 15–45 minutes. Each interview was audio-recorded, transcribed verbatim, and de-identified for data analysis. Prior to data collection, participants were provided with a research ethics board (REB)-approved information letter that described the study in accessible language and provided sufficient information for participants to make an informed decision about their participation. They were given ample time to review and ask questions. Thereupon, verbal informed consent was obtained during the interview and documented on a REB-approved verbal informed consent log for audio and/or video recording and the use of quotes. This study was reviewed and approved by the Hamilton Integrated Research Ethics Board (Project number 15023; McMaster University).

Data analysis

Data analysis involved conventional (inductive) content analysis [14,20,21]. We collected and analyzed data concurrently. Two research team members iteratively read the transcripts to derive codes by highlighting text that captured key thoughts or concepts. Subsequently, labels for codes were actively constructed from the text and formed the initial coding scheme. We grouped the codes into categories based on their relationships and connections, which helped organize codes into meaningful groups [20]. To ensure the authenticity and completeness of the identified concepts and their overarching categories, two members coded all transcripts independently and in duplicate in a triangulated approach. We also captured representative quotes for the identified categories.

To compare themes in each country, we used an integrated, joint, side-by-side display [22]. We illustrated concepts in Venn diagrams to identify similarities and differences between jurisdictions. We summarized demographic data using ranges and proportions. We used Dedoose (v9.0.90) for data management and analysis.

Strategies to promote rigor and trustworthiness

The term “bias” is generally drawn from quantitative research and is incompatible with the philosophical underpinnings of qualitative methodology as the subjectivity resulting from the researcher is integral to qualitative research [15]. Accordingly, to enhance the credibility of the data, the research team comprised expert qualitative researchers, orthopaedic surgeons, an experienced orthopaedic research coordinator, and experts in chronic pain management. The team had peer debriefing meetings to ensure conceptual ideas were explored and well-organized. We also used triangulation to enhance the trustworthiness of our findings [23]. We used member checking, where we asked participants to check the completeness of the summary of findings based on their responses at the end of the interview. The interviewers also developed positionality statements (S2 File), and kept a field diary and a reflective journal to ensure interpretive authority [24]. Potential power imbalances were minimized as interviews were conducted by graduate and undergraduate students with no authority or influence over participants’ careers.

Inclusivity in global research

Additional information regarding the ethical, cultural, and scientific considerations specific to inclusivity in global research is included in the Supporting Information (S4 File).

Results

Characteristics of participants

Out of the 27 participants in the study, the majority were men (n = 21, 78%) (Table 1). The length of surgical practice varied, ranging from less than one year to 28 years. Sixty-three percent of included surgeons practiced in academic settings. In-hospital stay post-operation was 0–3 days for both TKA and THA in Canada and the Netherlands, and 10–30 days in Japan. Interviewed surgeons in Canada and the Netherlands reported that all or almost all their patients were prescribed opioids after discharge. In contrast, surgeons in Japan showed much greater variability, with half prescribing opioids to all patients and the other half prescribing opioids to only a minority or no patients after discharge. In addition, during interviews, Canadian and Dutch orthopaedic surgeons indicated use of a wider range of opioids as compared to Japanese surgeons, who predominantly prescribed NSAIDs and tramadol (S3 File).

thumbnail
Table 1. Demographic and practice characteristics of participating orthopaedic surgeons in Canada, The Netherlands, and Japan.

https://doi.org/10.1371/journal.pone.0331335.t001

We grouped data on barriers and facilitators to opioid reduction into six categories (S3 File, S1 and S2 Figs). Examples of quotes representing each theme can be found in Table 2.

thumbnail
Table 2. Categories of barriers and facilitators to reduced opioid prescribing identified by surgeons.

https://doi.org/10.1371/journal.pone.0331335.t002

Category 1: Surgeons’ prescribing practices

We identified several facilitators to opioid reduction emerging from surgeons’ interview responses (S3 File, S1 and S2 Figs). Canadian and Dutch surgeons included in our study stated that they had decreased the quantity and duration of opioid prescriptions over time, with many currently prescribing opioids as-needed. Moreover, during interviews, Canadian and Dutch surgeons shared concerns about misuse and the adverse effects of opioids, specifically addiction. Conversely, Japanese surgeons expressed apprehension about additional side effects, such as falls, sedation, nausea, constipation, and hepatic dysfunction, in addition to addiction. Many Japanese surgeons interviewed in this study believed that opioids were not necessary for pain management after discharge and preferred to use non-opioid alternatives such as NSAIDs or paracetamol. However, half of the Japanese surgeons we interviewed prescribed tramadol to all their patients on discharge. Meanwhile, in the Netherlands, all included surgeons described using a standard institutional protocol for postoperative/discharge pain management, which reduced variations in prescribing practices among colleagues.

Participating surgeons in all three countries reported encountering several barriers and challenges to opioid reduction. Dutch and Canadian surgeons highlighted the tension they faced between the need to relieve patients’ pain and preserve their mobility while minimizing the risks of opioid use. These surgeons also noted that busy schedules hindered their ability to monitor patients’ opioid use. Although many Dutch surgeons who were interviewed followed standard institutional protocols for postoperative and discharge prescribing, some surgeons were unfamiliar with the specific details because anesthesiologists handled postoperative pain management at some institutions. However, most Canadian and Japanese orthopaedic surgeons in our study did not describe using a standard institutional protocol. Many Canadian surgeons perceived that senior orthopaedic surgeon exhibited resistance to reducing opioids and had outdated prescribing practices. They also pointed out that differences in individual surgeons’ preferences, experiences, and training may explain variations in prescribing practices.

Category 2: Patient factors

All Dutch and Canadian orthopaedic surgeons interviewed in our study reported that either they or a member of the care team provided patients with pre- and postoperative education about pain expectations, medications, and potential side effects (S3 File, S1 and S2 Figs). Dutch surgeons also described offering education about the pain management ladder, which prioritizes non-opioid analgesics first and strategies for tapering opioid use. Some Japanese surgeons did not provide patient education regarding analgesia as they believed it was only necessary when prescribing strong opioids. Orthopaedic surgeons in Japan noted that cultural factors led to resistance to opioid use among some Japanese patients, who preferred non-opioid pain management options.

Canadian and Dutch participants shared concerns about the potential for patients to divert unused opioids; however, most surgeons reported that they did not provide instructions to patients about how to properly dispose of unused opioids. Surgeons in both countries expressed concerns about patient dissatisfaction with reduced quantity/dosage of opioids and the use of non-opioid pain management modalities. Canadian and Dutch surgeons also noted that patients frequently harbored unrealistic expectations of being entirely pain-free following surgery, making it challenging to decrease opioid prescribing.

Category 3: Collaborative care

Orthopaedic surgeons from Canada and the Netherlands interviewed in this study reported collaborations with other healthcare providers, pain clinics, and pharmaceutical departments to enhance patient care and education, to receive education on opioid prescribing, and to develop a standardized pain management protocol within their institutions (S3 File, S1 and S2 Figs). These collaborations also aimed to provide optimal care for patients with substance use disorders.

Many orthopedic surgeons that we interviewed shared apprehensions about patients obtaining opioid refills from other healthcare providers without their knowledge or authorization. Also, Canadian surgeons expressed challenges with referring patients to pain clinics for more specialized care as these clinics often had long wait times. In contrast, many Japanese surgeons described that their institution lacked a specialized pain management team, making it challenging for them to refer patients with greater needs to professionals who are more experienced in managing pain. Dutch surgeons in our study described inconsistencies in opioid prescribing patterns and attitudes among healthcare professionals within a patient’s care team, especially if providers other than the surgeon were involved in prescribing.

Category 4: Policies, guidelines, and regulations on opioid prescribing

During the interviews, many Canadian surgeons identified provincial campaigns on opioid reduction and institutional regulations and monitoring as facilitators of opioid reduction (S3 File, S1 Fig). Notably, some Canadian surgeons perceived reluctance in the orthopaedic community to prescribe opioids due to fear of litigation or license suspension. Moreover, some Japanese surgeons in our study highlighted that regulations on more potent opioids restricted their ability to prescribe them. However, most Canadian and Japanese surgeons lacked knowledge about existing guidelines for opioid prescribing (S2 Fig). Some Canadian surgeons believed that current policies and guidelines on peri-operative opioid use were outdated. Some also felt that the strict opioid prescribing policies and restrictions placed pressure on them and hindered their ability to provide individualized care, particularly for patients experiencing severe pain.

Category 5: Opioid risk mitigation via continuing surgeon education

Included orthopaedic surgeons from all three countries discussed their experiences and perspectives on continuing education regarding safer opioid prescribing (S3 File, S1 and S2 Figs). Some Canadian and Dutch orthopedic surgeons were actively involved in opioid-related research and were members of arthroplasty or orthopedic groups and societies. Others recalled receiving institutional/departmental training on pain management and opioid prescribing (i.e., through modules, meetings, rounds, and conferences). Conversely, while some Japanese institutions provided additional training and guidance on opioid prescribing, many interviewed surgeons reported completing external e-learning modules for every type of opioid that they prescribed.

During interviews, some surgeons in all three countries stated that they had not received any specific education on opioid prescribing after their medical training. While some of these surgeons did not see the need for further education, others recognized its importance. For example, Canadian surgeons emphasized the need for more education on identifying abuse, pain management for vulnerable populations, dosing, non-opioid alternatives, and prescribing trends, with a preference for online and short educational sessions. Likewise, Dutch surgeons in our study identified a need of formal education on available multimodal pain management protocols, relevant literature updates, novel products, and emerging non-opioid alternatives. Japanese surgeons highlighted the need for education on risk factors for substance use disorder and postoperative pain management strategies for patients at risk of substance use disorders.

Category 6: Personal perceptions and beliefs towards opioid prescribing

Orthopaedic surgeons that we interviewed from Canada, the Netherlands, and Japan had varying perceptions of opioid prescribing, but some similarities were observed (S3 File, S1 Fig). Many Canadian and Dutch surgeons believed that opioids are necessary for improving patients’ sleep and mobility and, subsequently, cannot be eliminated from post-THA/TKA pain management protocols. Almost all Japanese orthopaedic surgeons that we interviewed considered tramadol less addictive than other opioids, but some desired more potent and longer-duration opioids. Many included surgeons from Japan and the Netherlands exhibited knowledge gaps and uncertainty regarding the use of opioids for patients with substance use disorders.

Discussion

We found that all orthopaedic surgeons that we interviewed from Canada and almost all from the Netherlands prescribed opioids to every patient after joint replacement surgery. However, Japanese surgeons in our sample exhibited much greater variability, with half prescribing opioids to all patients and half prescribing to only a minority of patients or none. Consistent with other literature, our findings suggest differences in prescribing practices between Canadian, Dutch, and Japanese orthopaedic surgeons emanate from individual, patient, and system-level disparities [2528].

Many included orthopaedic surgeons from Japan believed that opioids are largely unnecessary for managing postoperative pain, as opposed to their counterparts from Canada and the Netherlands, who believed that opioids cannot completely be eliminated from postoperative pain management protocols. A survey comparing opioid prescribing patterns among 164 orthopaedic surgeons in the USA and Japan also reported that more participants in the USA strongly believed that opioids are necessary for outpatient post-surgical pain control compared to those in Japan (23% in the USA vs. 3% in Japan) [28]. Likewise, a cross-sectional survey of 981 patients from the USA and seven other countries reported that more American patients were given opioids after discharge compared with those in other countries [27]. All Dutch surgeons that we interviewed used an evidence-based, institutional standard pain protocol and an analgesic ladder, recommending non-opioid therapies as the first line of treatment. In contrast, most surgeons that we included from Canada and Japan did not describe the use of a standardized protocol for analgesia after surgery. Several studies have reported that the implementation of standard institutional protocols restricting opioid use has resulted in lower mean consumption of opioids, underscoring the need for institutions to establish standardized protocols and ensure adherence [2931].

Canadian and Dutch surgeons in our study seldom instructed patients on how to dispose of unused opioid medications. Consistent provision of instructions to patients regarding safe storage and disposal methods may serve as a preventive measure against the diversion of unused opioids for potential abuse or misuse [32,33]. Japanese surgeons that we interviewed perceived that instructions on leftover medications were unnecessary. However, a cross-sectional study involving 387 Japanese patients with chronic non-cancer pain revealed that 38% met criteria for opioid misuse and 17% met criteria for opioid abuse [34]. Included surgeons also reported challenges with patients procuring opioid refills from other healthcare providers. A 2018 survey of 2772 US orthopedic trauma patients found that 20% engaged in “doctor shopping” for additional opioids after surgery, highlighting the need for improved communication between primary care and surgeons [35]. Moreover, this underscores the continued importance of educating patients on the risks associated with opioids, expectations of pain management, exploring alternative treatment options, and providing guidance on safe handling and proper disposal methods. A systematic review of 11 studies, evaluating the effectiveness of pre-operative patient education on post-operative opioid use and pain management in the orthopaedic setting, found that education related to opioid use and pain can be effective in reducing opioid prescription requests and filling [36]. Similarly, a cluster-randomized controlled trial including 539 patients reported that patient education on safe opioid disposal approximately triples opioid disposal rates compared with no education [33].

The surgeons that we interviewed from Japan highlighted a social and cultural resistance among their patients to using opioids and, thus, a preference for non-opioid analgesia. This inclination may stem concomitantly from the perception that chronic opioid use may be a criminal offense and cultural mores regarding self-attention, discouraging individuals from voicing pain-related concerns [4]. Moreover, an observational study found that American patients reported higher chronic pain incidence and greater opioid load overall [37]. Japanese surgeons we interviewed that prescribed only opioids administered tramadol, which they perceived as safer than other opioids. However, tramadol’s pain-relieving effects depend on opioid metabolites, the quantities of which can differ among individuals due to genetic variations. Consequently, this divergence can lead to varying levels of risk associated with their use. From 2015 to 2017 in the USA, past-year misuse of oral tramadol was approximately 4%, which was lower than that of other opioids [38].

Differences in perceptions of facilitators and barriers between Canada, the Netherlands, and Japan may also stem from variability in healthcare systems. Specifically, Japan has a national insurance system that strictly enforces the indications for each medication, and non-compliance results in a lack of insurance coverage. For instance, the use of oxycodone is only covered by insurance for treating cancer pain and cannot be prescribed for other types of pain [4]. Additionally, Japanese physicians prescribing opioids for chronic non-cancer pain must fulfill several requirements: the physician must have completed e-learning modules for each specific opioid, the physician and patient must sign a contract prior to initiating opioid therapy, the patient must be prescribed non-opioid analgesics first, and the patient must undergo trial use of a challenge opioid to ensure effectiveness [4]. Also, Japanese surgeons included in our study described that patients are hospitalized for several weeks following most elective surgeries, in contrast to the Canadian or Dutch healthcare systems, which are rapidly transitioning towards outpatient care settings. During hospitalization, Japanese patients receive intensive rehabilitation and pain management while closely monitored by medical and nursing staff, resulting in their exposure to opioid medication being subject to strict surveillance [28]. Similarly, many European countries enforce regulatory restrictions on the prescribing of opioids including dose limits, duplicate or triplicate prescriptions using special forms, and strict monitoring by pharmacies [39].

Most surgeons were aware of institutional regulations and restrictions on opioid prescribing, but many surgeons in Canada and the Netherlands lacked knowledge of existing guidelines and policies. The Canadian Orthopedic Association’s position statement on opioid prescribing highlights the use of the 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain which offers direction for physicians in Canada regarding the prescription of opioids and advocates for a more conservative approach [40,41]. This guideline is complementary to several province-specific resources and practice standards such as the Safe Prescribing of Opioids and Sedatives practice standard by the College of Physicians and Surgeons of British Columbia and the Public Health Ontario Interactive Opioid Tool [42]. Moreover, the CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022, provides recommendations for clinicians prescribing opioids to adult outpatients [43]. Recently, clinical practice recommendations were developed for prescribing opioids to patients with chronic noncancer pain in Europe [44]. However, there is a need for surgery-specific guidelines on opioid prescribing to promote evidence-based practices. Notably, a retrospective cohort study, evaluating postoperative opioid prescription quantities, variability, and 30-day refill rates before and after implementation of orthopedic procedure-specific guidelines reported decreased opioid prescription amounts and variability [45].

Cross-national insights can be integrated into the development of surgery-specific opioid prescribing guidelines. The variability observed across Canada, the Netherlands, and Japan highlights the need for evidence-based protocols that account for both cultural contexts and patient preferences. Our findings suggest that surgeon training programs can integrate updated guidance on multimodal pain management strategies, safe opioid prescribing, and the importance of educating patients on proper storage and disposal of unused opioid medications. Emphasizing existing national and international guidelines within training can further support consistent, informed decision-making. Addressing the identified barriers will require a multifaceted approach, including system-level changes and targeted educational interventions. Future research can evaluate the effectiveness of such strategies in supporting surgeons to adopt patient-centered, evidence-based practices that minimize opioid use while ensuring adequate pain control. Multi-center, quantitative studies are also needed to improve generalizability and explore cultural influences on prescribing behavior. Additionally, qualitative and quantitative studies exploring patient perspectives may offer a more holistic understanding of pain management preferences and inform more tailored interventions.

Strengths

Our study provides a cross-cultural understanding of opioid prescribing practices by exploring the perspectives of orthopedic surgeons across three countries that represent high (Canada), moderate (the Netherlands), and low (Japan) opioid prescribing practices. The qualitative approach allows for an in-depth exploration of nuanced barriers and facilitators that may not be captured through quantitative methods. Additionally, we implemented triangulation and member checking to enhance the trustworthiness of our findings.

Limitations

Our study involved surgeons who volunteered to participate and, thus, may have had a heightened interest or stronger perceptions regarding opioid use and prescribing. Also, there were considerably more men than women participants in our study, likely reflecting the under-representation of women in arthroplasty in all three countries of interest [46]. Our results may not be transferable to other settings due to differences in population makeup and cultures. Moreover, our sample primarily consisted of surgeons practicing in academic settings, which may stem from inherent limitations in convenience and snowball sampling. As qualitative studies seek to understand a specific phenomenon, generalizability is not an expected attribute as it is for quantitative studies. Additionally, interviews were conducted in English, which may have created comprehension difficulties for some Japanese surgeons. However, we provided the option of a translator if necessary. Although there is a potential for social desirability bias in participants’ responses, we endeavored to minimize this bias by ensuring that there were no leading questions, using indirect questioning, probing and clarifying participant responses, and providing assurance of confidentiality and anonymity prior to commencing the interviews [47].

Conclusions

Canadian, Dutch, and Japanese orthopedic surgeons in our study delineated a range of individual, patient, and system level contributors to variability in opioid prescribing after joint replacement surgery. These findings suggest that multifactorial and context-specific approaches may be required to address barriers and optimize postoperative use of opioids. Rigorous quantitative studies, with larger sample sizes, are needed to validate these qualitative findings and assess their generalizability across broader populations. Additionally, further qualitative and quantitative studies, exploring patient perspectives on opioid use, are needed for achieving a more comprehensive understanding of the issue.

Supporting information

S1 File. Semi-Structured Interview Guide (30–45 Minutes).

https://doi.org/10.1371/journal.pone.0331335.s001

(DOCX)

S2 File. Interviewer Positionality Statements.

https://doi.org/10.1371/journal.pone.0331335.s002

(DOCX)

S3 File.

S3 Table 1. Pain medications prescribed by orthopaedic surgeons in Canada, Japan, and the Netherlands. S3 Table 2. Facilitators and barriers to reduced opioid prescribing influencing surgeons’ prescribing practises. S3 Table 3. Facilitators and barriers to reduced opioid prescribing related to patient factors/perspectives. S3 Table 4. Facilitators and barriers to reduced opioid prescribing related to providing collaborative patient care. S3 Table 5. Facilitators and barriers to reduced opioid prescribing related to policies, guidelines, and regulations on opioid prescribing. S3 Table 6. Barriers and facilitators to reduced opioid prescribing related to opioid risk mitigation via surgeon education. S3 Table 7. Surgeons’ personal perceptions and beliefs on opioid prescribing.

https://doi.org/10.1371/journal.pone.0331335.s003

(DOCX)

S1 Fig. Comparison of factors perceived by surgeons as facilitating opioid reduction in Canada, Japan, and the Netherlands.

https://doi.org/10.1371/journal.pone.0331335.s004

(TIFF)

S2 Fig. Comparison of factors perceived by surgeons as hindering opioid reduction in Canada, Japan, and the Netherlands.

https://doi.org/10.1371/journal.pone.0331335.s005

(TIFF)

References

  1. 1. Latijnhouwers DAJM, Martini CH, Nelissen RGHH, Verdegaal SHM, Vliet Vlieland TPM, Gademan MGJ, et al. Acute pain after total hip and knee arthroplasty does not affect chronic pain during the first postoperative year: observational cohort study of 389 patients. Rheumatol Int. 2022;42(4):689–98. pmid:35218380
  2. 2. Chaudhary MA, Dalton MK, Koehlmoos TP, Schoenfeld AJ, Goralnick E. Identifying patterns and predictors of prescription opioid use after total joint arthroplasty. Mil Med. 2021;186(5–6):587–92. pmid:33484147
  3. 3. Jalali MS, Botticelli M, Hwang R, Koh H, McHugh R. The opioid crisis: a contextual, social-ecological framework. 2020.
  4. 4. Onishi E, Kobayashi T, Dexter E, Marino M, Maeno T, Deyo RA. Comparison of opioid prescribing patterns in the united states and japan: primary care physicians’ attitudes and perceptions. J Am Board Fam Med. 2017;30(2):248–54. pmid:28379832
  5. 5. Loh FE, Herzig SJ. Pain in the United States: time for a culture shift in expectations, messaging, and management. J Hosp Med. 2019;14(12):787–8. pmid:31339835
  6. 6. Ladha KS, Neuman MD, Broms G, Bethell J, Bateman BT, Wijeysundera DN, et al. Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Netw Open. 2019;2(9):e1910734. pmid:31483475
  7. 7. Humphreys K, Shover CL, Andrews CM, Bohnert ASB, Brandeau ML, Caulkins JP, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet. 2022;399(10324):555–604. pmid:35122753
  8. 8. Federal p, territorial Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid- and stimulant-related harms in Canada. In: Canada OPHA o, editor. 2023.
  9. 9. Verhamme KMC, Bohnen AM. Are we facing an opioid crisis in Europe? Lancet Public Health. 2019;4(10):e483–4. pmid:31444002
  10. 10. Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4(10):e498–505. pmid:31444001
  11. 11. Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD. Current perspectives on the opioid crisis in the US healthcare system: A comprehensive literature review. Medicine (Baltimore). 2019;98(20):e15425. pmid:31096439
  12. 12. Greberman SB, Wada K. Social and legal factors related to drug abuse in the United States and Japan. Public Health Rep. 1994;109(6):731–7. pmid:7800780
  13. 13. Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23(4):334–40. pmid:10940958
  14. 14. Laupacis M, Acai A, MacMillan HL, Vanstone M, Stewart D, Dimitropoulos G, et al. A qualitative description of resident physicians’ understanding of child maltreatment: impacts, recognition, and response. Int J Environ Res Public Health. 2022;19(6):3319. pmid:35329006
  15. 15. Luciani M, Jack SM, Campbell K, Orr E, Durepos P, Li L, et al. An introduction to qualitative health research. Prof Inferm. 2019;72(1):60–8. pmid:31162045
  16. 16. Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40(1):23–42. pmid:27686751
  17. 17. Thorne S. Interpretive description: qualitative research for applied practice. 2 ed. New York: Routledge; 2016.
  18. 18. Desveaux L, Saragosa M, Kithulegoda N, Ivers NM. Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study. BMC Fam Pract. 2019;20(1):59. pmid:31077137
  19. 19. Bergman AA, Matthias MS, Coffing JM, Krebs EE. Contrasting tensions between patients and PCPs in chronic pain management: a qualitative study. Pain Med. 2013;14(11):1689–97. pmid:23870100
  20. 20. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. pmid:16204405
  21. 21. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–15. pmid:18352969
  22. 22. McCrudden MT, Marchand G, Schutz PA. Joint displays for mixed methods research in psychology. Methods Psychol. 2021;5:100067.
  23. 23. Patton MQ. Enhancing the quality and credibility of qualitative analysis. Health Serv Res. 1999;34(5 Pt 2):1189–208. pmid:10591279
  24. 24. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57. pmid:17872937
  25. 25. Manjiani D, Paul DB, Kunnumpurath S, Kaye AD, Vadivelu N. Availability and utilization of opioids for pain management: global issues. Ochsner J. 2014;14(2):208–15. pmid:24940131
  26. 26. Neuman MD, Bateman BT, Wunsch H. Inappropriate opioid prescription after surgery. Lancet. 2019;393(10180):1547–57. pmid:30983590
  27. 27. Burden M, Keniston A, Wallace MA, Busse JW, Casademont J, Chadaga SR, et al. Opioid utilization and perception of pain control in hospitalized patients: a cross-sectional study of 11 sites in 8 countries. J Hosp Med. 2019;14(12):737–45. pmid:31339840
  28. 28. Tannoury C, Kleweno C, Kamath AF, Gary J. Comparison of opioid use and prescribing patterns in orthopedic surgery in Japan and the United States: A JOA-AOA traveling fellowship investigation. J Orthop Sci. 2020;25(3):520–4. pmid:31155440
  29. 29. Wyles CC, Hevesi M, Trousdale ER, Ubl DS, Gazelka HM, Habermann EB, et al. The 2018 Chitranjan S. Ranawat, MD Award: developing and implementing a novel institutional guideline strategy reduced postoperative opioid prescribing After TKA and THA. Clin Orthop Relat Res. 2019;477(1):104–13. pmid:30794233
  30. 30. Vaz KM, Huang PS, Copp SN. Standardized opioid prescription protocol reduces opioid consumption after total joint arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2019;3(12):e19.00163. pmid:32072125
  31. 31. Holte AJ, Carender CN, Noiseux NO, Otero JE, Brown TS. Restrictive opioid prescribing protocols following total hip arthroplasty and total knee arthroplasty are safe and effective. J Arthroplasty. 2019;34(7S):S135–9. pmid:30890390
  32. 32. Sundararajan K, Ajrawat P, Canizares M, Power JD, Perruccio AV, Sarro A, et al. The potential for diversion of prescribed opioids among orthopaedic patients: Results of an anonymous patient survey. PLoS One. 2021;16(8):e0256741. pmid:34437639
  33. 33. Nahhas CR, Hannon CP, Yang J, Gerlinger TL, Nam D, Della Valle CJ. Education increases disposal of unused opioids after total joint arthroplasty: a cluster-randomized controlled trial. J Bone Joint Surg Am. 2020;102(11):953–60. pmid:32251139
  34. 34. Takasusuki T, Hayashi S, Koretaka Y, Yamaguchi S. Prevalence of and risk factors for prescription opioid misuse, abuse, diversion and doctor shopping in Japan: a survey study. Pain Ther. 2022;11(3):987–1009. pmid:35790601
  35. 35. Spears TM, Harrison JM, Spooner RB, Douglas TJ, Balazs GC. Patient expectations for opioid analgesia following orthopaedic surgery. Postgrad Med J. 2022;98(e1):e64–5. pmid:35105780
  36. 36. Rucinski K, Cook JL. Effects of preoperative opioid education on postoperative opioid use and pain management in orthopaedics: a systematic review. J Orthop. 2020;20:154–9. pmid:32025140
  37. 37. Zaslansky R, Meissner W, Chapman CR. Pain after orthopaedic surgery: differences in patient reported outcomes in the United States vs internationally. An observational study from the PAIN OUT dataset. Br J Anaesth. 2018;120(4):790–7. pmid:29576119
  38. 38. Reines SA, Goldmann B, Harnett M, Lu L. Misuse of Tramadol in the United States: an analysis of the national survey of drug use and health 2002-2017. Subst Abuse. 2020;14:1178221820930006. pmid:32547049
  39. 39. van Amsterdam J, van den Brink W. The misuse of prescription opioids: a threat for Europe? Curr Drug Abuse Rev. 2015;8(1):3–14. pmid:26084418
  40. 40. Jason WB, Samantha C, David NJ, Buckley DN, Li W, Rachel JC, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659–66. pmid:28483845
  41. 41. COA position statement: opioids and orthopaedic surgical practice. COA; 2018.
  42. 42. BotCoPa Surgeons. Safe prescribing of opioids and sedatives. Columbia oB; 2022.
  43. 43. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. pmid:36327391
  44. 44. Häuser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, et al. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: Role of opioids in the management of chronic noncancer pain. Eur J Pain. 2021;25(5):949–68. pmid:33655607
  45. 45. Wyles CC, Hevesi M, Ubl DS, Habermann EB, Gazelka HM, Trousdale RT, et al. Implementation of procedure-specific opioid guidelines: a readily employable strategy to improve consistency and decrease excessive prescribing following orthopaedic surgery. JB JS Open Access. 2020;5(1):e0050. pmid:32309760
  46. 46. Hunter J, Grewal R, Nam D, Lefaivre KA. Gender disparity in academic orthopedic programs in Canada: a cross-sectional study. Can J Surg. 2022;65(2):E159–69. pmid:35264443
  47. 47. Bergen N, Labonté R. “Everything is perfect, and we have no problems”: detecting and limiting social desirability bias in qualitative research. Qual Health Res. 2020;30(5):783–92. pmid:31830860